ICU Medical (NASDAQ:ICUI) Share Price Passes Above Two Hundred Day Moving Average – Time to Sell?

Shares of ICU Medical, Inc. (NASDAQ:ICUI) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $138.91 and traded as high as $157.64. ICU Medical shares last traded at $157.60, with a volume of 155,803 shares.

Analysts Set New Price Targets

ICUI has been the topic of several research analyst reports. Wall Street Zen raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Weiss Ratings upgraded shares of ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, May 11th. Jefferies Financial Group raised ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. Sanford C. Bernstein downgraded ICU Medical to a “market perform” rating in a research report on Monday, June 15th. Finally, Piper Sandler decreased their price target on ICU Medical from $178.00 to $163.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Three investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, ICU Medical has a consensus rating of “Buy” and an average target price of $168.40.

ICU Medical Price Performance

The company has a fifty day simple moving average of $138.59 and a 200-day simple moving average of $138.95. The company has a market cap of $3.95 billion, a P/E ratio of 85.38, a PEG ratio of 2.20 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.34 and a quick ratio of 1.17.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, beating the consensus estimate of $1.78 by $0.19. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The business had revenue of $525.77 million during the quarter, compared to the consensus estimate of $520.65 million. During the same period in the prior year, the business posted $1.72 earnings per share. ICU Medical’s revenue was down 12.3% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, sell-side analysts predict that ICU Medical, Inc. will post 6.51 earnings per share for the current year.

Insider Transactions at ICU Medical

In other ICU Medical news, Director David C. Greenberg sold 2,424 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $122.91, for a total transaction of $297,933.84. Following the completion of the sale, the director directly owned 7,960 shares of the company’s stock, valued at approximately $978,363.60. This represents a 23.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Virginia Ruth Sanzone sold 2,447 shares of the firm’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $124.08, for a total transaction of $303,623.76. Following the completion of the transaction, the vice president owned 19,460 shares of the company’s stock, valued at approximately $2,414,596.80. The trade was a 11.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 2.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On ICU Medical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Maryland State Retirement & Pension System lifted its stake in ICU Medical by 2.0% during the fourth quarter. Maryland State Retirement & Pension System now owns 3,619 shares of the medical instruments supplier’s stock worth $516,000 after purchasing an additional 70 shares during the period. California Public Employees Retirement System grew its stake in shares of ICU Medical by 0.3% in the 1st quarter. California Public Employees Retirement System now owns 30,461 shares of the medical instruments supplier’s stock valued at $3,934,000 after purchasing an additional 90 shares during the period. Oregon Public Employees Retirement Fund grew its stake in shares of ICU Medical by 1.8% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 5,631 shares of the medical instruments supplier’s stock valued at $803,000 after purchasing an additional 100 shares during the period. Smartleaf Asset Management LLC raised its holdings in shares of ICU Medical by 11.6% in the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after buying an additional 101 shares in the last quarter. Finally, Lido Advisors LLC raised its holdings in shares of ICU Medical by 4.5% in the 4th quarter. Lido Advisors LLC now owns 2,479 shares of the medical instruments supplier’s stock worth $354,000 after buying an additional 106 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.